I am committed to doing everything within my power to cultivate support for this bill, and I hope you will join me. #LongCovidMoonshot Press release by Sen. Bernie Sanders sanders.senate.gov/media/press-re…

Wonderful, wonderful, wonderful review on Long COVID.

ICYMI #LongCovid is a defining crisis of our time Long Covid affects at least 400 million people globally with an economic cost of $1 trillion/yr Addressing Long Covid requires a coordinated—but so far absent—response strategy Our review Nature Medicine nature.com/articles/s4159…

长期新冠疫情是我们这个时代的一场决定性危机。 长期新冠疫情影响全球至少 4 亿人，每年造成 1 万亿美元的经济损失。 我们在Nature Medicine 上的评论 nature.com/articles/s4159…

I’ll be speaking at the NIH RECOVER: Treating #LongCovid workshop on September 23. I’d love to include input from the community. Please share your thoughts. Workshop goals are here: web.cvent.com/event/11825c60…

This is very important for people to understand. Immunity against SARS-CoV-2 - wanes/declines/disappears with time (months). This applies to immunity from natural infection and vaccine-derived immunity.

✨I’m thrilled to be one of the speakers at the 2024 inaugural TIME100 Health Leadership Forum in New York City today. After the event, the highlights will be available on time.com TIME #TIME100HEALTH

How the Pandemic Increased US Deaths! Visualized in 8 charts by Jason Gale in Bloomberg 1. The Covid Pandemic Fueled a 4-Year Mortality Surge in the US

1. What are the benefits and risks of GLP1? Our new study in @naturemedicine comprehensively maps all the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound). By Yan Xie, Taeyoung Choi and me 🧵 nature.com/articles/s4159…

🚨 New from my team: In a study of over 2 million people, we comprehensively mapped the benefits and risks of GLP-1 (weight loss drugs) across 175 health conditions. 📄 Free access to the full study: rdcu.be/d6VYU 🧵 Explore the key findings: x.com/zalaly/status/…

🚨 I dive into the benefits and risks of Ozempic and similar weight loss drugs in this article for The Conversation U.S. 💊 These drugs may lower the risk of 42 health conditions but aren’t without risks theconversation.com/ozempic-and-si… Free PDF of original article rdcu.be/d6VYU

🚨 ICYMI: Our latest study shows that the popular GLP-1 weight loss drugs (e.g. Ozempic) have broad health benefits — reducing risks of 42 health conditions. They are not without risks — increasing risks of of 19 health conditions. nature.com/articles/s4159…

Thanks to Derek Thompson for hosting me on his podcast. We talked about the GLP-1 and more. Details in this post below.

New Long Covid policy paper from Norway outlines knowledge gaps and lessons learnt for developing preparedness for future pandemics. Section 5 (pictured below) outlines their recommendations. Led by Sara Illman, PhD and colleagues. nordforsk.org/2025/knowledge…

This thread is a great explainer of our paper on the benefits and risks GLP-1 drugs nature.com/articles/s4159… Thanks F. Perry Wilson, MD MSCE for this informative thread.

For decades, the junk food industry has deliberately engineered foods to be addictive. Ozempic and other GLP-1 drugs have helped people break free from this cycle. In response, the industry is now searching for ways to counteract the effects of these medications, aiming to design

In a national cohort of veterans, the 2024–2025 Covid-19 vaccine was linked to reduced risks of emergency department visits, hospitalizations, and deaths from Covid-19 across the overall cohort and in various subgroups. Full study results: undefined